Insulin-like growth factor-I and bone mineral density

Area of Science:

• Endocrinology
• Bone Biology
• Gerontology

Background:

• Postmenopausal osteoporosis is a significant health concern.
• Insulin-like growth factor-I (IGF-I) plays a role in bone metabolism.
• The relationship between IGF-I and bone mineral density (BMD) requires further elucidation in postmenopausal women.

Purpose of the Study:

• To investigate the association between serum insulin-like growth factor-I (IGF-I) and bone mineral density (BMD).
• To explore correlations between IGF-I, its binding protein-3 (IGFBP-3), and bone turnover markers.

Main Methods:

• Cross-sectional study of 201 healthy postmenopausal women.
• BMD measured at lumbar spine and hip using dual-energy X-ray absorptiometry.
• Serum levels of IGF-I, IGFBP-3, parathyroid hormone (PTH), osteocalcin (OC), bone-specific alkaline phosphatase (BALP), tartrate-resistant acid phosphatase (TRAP), and carboxyterminal propeptide of type I procollagen (PICP) were analyzed.

Main Results:

• Serum IGF-I showed significant correlations with age, osteocalcin, BALP, and TRAP.
• No significant correlation was found between serum IGF-I and BMD at any site.
• While IGF-I and IGFBP-3 were strongly correlated, IGFBP-3 did not correlate with BMD or bone turnover markers.

Conclusions:

• IGF-I is related to markers of bone turnover in postmenopausal women.
• There is no direct relationship identified between IGF-I and bone mineral density in this cohort.
• IGF-I's role in postmenopausal bone health may be indirect or related to bone turnover rather than density.